Positive Expiratory Pressure (PEP) Devices Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2026

Excess mucus is associated with pulmonary infections and are linked with 50% of COPD hospital admissions across the globe. Impaired airway clearance in patients suffering from lung diseases leads to further destruction of lung tissues. Positive expiratory pressure therapy (PEP) is one of the frequently used options for airway clearance therapy. It can be used in addition to the traditional pressure therapy in lung diseases. In PEP devices, a person breathes through a handheld mouthpiece or mask. This helps air to get behind the mucus in the lungs and move it from the airway walls. The device allows air to pass freely as the patient breathes in, and involves active expiration of the inhaled air against the resistance.

Read Report Overview: https://www.transparencymarketresearch.com/positive-expiratory-pressure-devices-market.html

Improved ventilation of lungs, efficient clearance of excessive mucus, and rise in prevalence of COPD are key factors expected to propel the PEP devices market during the forecast period. Labor-intensive and time consuming traditional methods of airway clearance are boosting the demand for advanced PEP devices across the globe. However, lack of awareness about technologically advanced airway clearance therapies in emerging countries is projected to restrain the PEP devices market in the near future.

Geographically, the global PEP devices market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global PEP devices market in 2017, owing to the rise in adoption of advanced airway clearance devices and increase in smoking and drinking in the U.S. This is boosting the patient pool for COPD in the U.S. and Canada. Europe also accounts for key share of the market, led by the strategic presence of prominent manufacturers in the region. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period due to the rise in geriatric population in China and Japan, and high penetration of key manufacturers in emerging countries of the region.

Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49881

Prominent players operating in the global PEP devices market include Smiths Medical, Aptalis Pharma US Inc., Philips Respironics, Monaghan Medical, D R Burton Healthcare Products LLC, and Pari Respiratory Equipment, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *